A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/44 (2006.01) A61K 31/415 (2006.01) A61K 31/4166 (2006.01) A61K 31/444 (2006.01) A61K 31/501 (2006.01) A61K 45/00 (2006.01) A61K 45/06 (2006.01) A61P 9/00 (2006.01) A61P 11/00 (2006.01) A61P 11/06 (2006.01) A61P 11/08 (2006.01) A61P 29/00 (2006.01) A61P 43/00 (2006.01)
Patent
CA 2372850
The invention relates to the combined use of the PDE4 inhibitor N- (3,5- dichloropyrid-4-yl)- 3-cyclopropylmethoxy- 4-difluoromethoxybenzamide, its pharmacologically tolerable salts or its N- oxide with a PDE3 inhibitor for the treatment of certain disease conditions such as, for example, acute or chronic obstructions of the bronchi.
L'invention concerne l'utilisation combinée de l'inhibiteur de la PDE4, N-(3,5-dichloropyrid-4-yl)-3-cyclopropylméthoxy-4-difluorométhoxybenzamide, de ses sels pharmaceutiquement tolérables ou de ses oxydes de N, avec un inhibiteur de la PDE3 pour le traitement de certains états pathologiques tels que, par exemple, des obstructions chronique ou aiguë des bronches.
Byk Gulden Lomberg Chemische Fabrik Gmbh
Gowling Lafleur Henderson Llp
Nycomed Gmbh
LandOfFree
Synergistic combination comprising roflumilast and a pde-3... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Synergistic combination comprising roflumilast and a pde-3..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synergistic combination comprising roflumilast and a pde-3... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1827429